Predicting Outcomes in Cirrhosis Patients With Gastrointestinal Bleeding Using Physiological Measures

What this Trial Is About

This research aims to evaluate whether physiological indicators like the quick Sequential Organ Failure Assessment, Shock Index, and related measures such as the Modified Shock Index, Age Shock Index, and Respiratory Adjusted Shock Index can accurately predict the outlook for patients with liver cirrhosis who experience gastrointestinal bleeding. Cirrhosis is a common chronic liver disease, and gastrointestinal bleeding is a serious complication with an uncertain prognosis. Developing reliable tools to assess risk can help improve emergency and critical care management for these patients. The study will observe and analyze the use of these physiological parameters in cirrhosis patients with gastrointestinal bleeding to understand their value in predicting patient outcomes. No specific treatment is given as this is an observational study focusing on assessing these indicators. Data will be collected throughout the study, which is expected to last an average of six months from the start date. Participants will be monitored using measures such as heart rate, blood pressure, and respiratory rate to calculate the Shock Index and its derivatives. Researchers will use these indicators to predict prognosis and assist in rapid treatment decisions. Study data will be gathered continuously until the studys completion, helping to improve medical care efficiency for critically ill cirrhosis patients with gastrointestinal bleeding.

Utilizing of Physiological Parameters Predict the Prognosis of Cirrhotic Patients With Gastrointestinal Bleeding